VANI - NASDAQ
Vivani Medical, Inc.
$1.28
-0.78%Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
At a Glance
Live SnapshotVivani Medical, Inc. Management Team
Mr. Donald Dwyer M.B.A.
Chief Business Officer & Corporate Secretary
Compensation
$190,969
Ms. Brigid Ann Makes M.B.A.
Chief Financial Officer and Principal Financial & Accounting Officer
Compensation
$204,626
Dr. Lisa E. Porter M.D.
Chief Medical Officer
Compensation
$493,800
Mr. Truc Le M.B.A.
Chief Operations Officer
Compensation
$493,800
Dr. Adam Mendelsohn Ph.D.
Co-Founder, Chief Executive Officer & Director
Compensation
$623,200
Vivani Medical, Inc. Insider Positioning
During the last 12 months, insiders have purchased $17.21M worth of VANI shares, with no selling activity reported.
3 Months
3.4M
4.33M
0
0.00
+4.3M
+$4.33M
3-6 Months
2.2M
3.02M
0
0.00
+3.0M
+$3.02M
6-9 Months
6.9M
9.63M
0
0.00
+9.6M
+$9.63M
9-12 Months
175.7K
223.10K
0
0.00
+223K
+$223K
Top Buyers
Williams Gregg
Director, 10 Percent Owner:
$17.01M
Mendelsohn Aaron
Director
$69K
Baker Wilford Dean
Director
$45K
Bradbury Daniel
Director
$45K
Popoff Alexandra L.
Director
$45K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $17.21M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
SEC Filings
VANI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | April 29, 2026 | December 31, 2025 | 2025 | |
DEF 14A DEF 14A 2025 N/A | April 29, 2025 | June 24, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 29, 2024 | June 27, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 28, 2023 | April 28, 2023 | ||
DEF 14A DEF 14A 2021 N/A | April 30, 2021 | May 28, 2021 | 2021 | |
DEF 14A DEF 14A 2019 N/A | April 25, 2019 | June 04, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 13, 2018 | May 16, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | May 01, 2017 | June 06, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | April 15, 2016 | April 12, 2016 | 2016 | |
DEF 14A DEF 14A 2015 N/A | April 16, 2015 | May 15, 2015 | 2015 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.